Page 2,028«..1020..2,0272,0282,0292,030..2,0402,050..»

Genetic Engineering – The New York Times

Posted: Published on April 7th, 2016

Latest Articles A genetically modified mosquito might eradicate the mosquito species that carries the Zika virus but must first survive a cumbersome approval process. By NINA FEDOROFF and JOHN BLOCK A Senate bill that would prevent states from requiring food labels to note the presence of genetically modified ingredients failed on Wednesday. By STEPHANIE STROM The senators will consider whether the government should require labeling on foods containing genetically engineered ingredients, an issue that has split the food industry. By JENNIFER STEINHAUER and STEPHANIE STROM A trial in the Florida Keys has been tentatively approved, but public comment must be assessed first by the agency. By ANDREW POLLACK A diverse biotechnology company hopes its genetically engineered mosquitoes can help stop the spread of a devastating virus. But thats just a start. By ANDREW POLLACK An official of a dairy association says G.M.O. products are safe and that any labeling rules should be national, not state by state. States should be free to require the labeling of genetically modified food if they want to. By THE EDITORIAL BOARD . By PAM BELLUCK Researchers worldwide have been observing a voluntary moratorium on changes to DNA that could be passed down to subsequent … Continue reading →

Posted in Genetic Engineering | Comments Off on Genetic Engineering – The New York Times

History of genetic engineering – Wikipedia, the free …

Posted: Published on April 7th, 2016

Genetic modification caused by human activity has been occurring since around 12,000 BC, when humans first began to domesticate organisms. Genetic engineering as the direct transfer of DNA from one organism to another was first accomplished by Herbert Boyer and Stanley Cohen in 1973. The first genetically modified animal was a mouse created in 1973 by Rudolf Jaenisch. In 1983 an antibiotic resistant gene was inserted into tobacco, leading to the first genetically engineered plant. Advances followed that allowed scientists to manipulate and add genes to a variety of different organism and induce a range of different effects. In 1976 the technology was commercialised, with the advent of genetically modified bacteria that produced somatostatin, followed by insulin in 1978. Plants were first commercialised with virus resistant tobacco released in China in 1992. The first genetically modified food was the Flavr Savr tomato marketed in 1994. By 2010, 29 countries had planted commercialized biotech crops. In 2000 a paper published in Science introduced golden rice, the first food developed with increased nutrient value. Genetic engineering is the direct manipulation of an organism's genome using certain biotechnology techniques that have only existed since the 1970s.[2] Human directed genetic manipulation was occurring much … Continue reading →

Posted in Genetic Engineering | Comments Off on History of genetic engineering – Wikipedia, the free …

Future Medicine, Ltd.

Posted: Published on April 7th, 2016

This site uses cookies to improve performance. If your browser does not accept cookies, you cannot view this site. There are many reasons why a cookie could not be set correctly. Below are the most common reasons: This site uses cookies to improve performance by remembering that you are logged in when you go from page to page. To provide access without cookies would require the site to create a new session for every page you visit, which slows the system down to an unacceptable level. This site stores nothing other than an automatically generated session ID in the cookie; no other information is captured. In general, only the information that you provide, or the choices you make while visiting a web site, can be stored in a cookie. For example, the site cannot determine your email name unless you choose to type it. Allowing a website to create a cookie does not give that or any other site access to the rest of your computer, and only the site that created the cookie can read it. Excerpt from: Future Medicine, Ltd. … Continue reading →

Posted in Future Medicine | Comments Off on Future Medicine, Ltd.

Mesenchymal Stem Cell Therapy for Lung Rejection – Full …

Posted: Published on April 7th, 2016

Primary Outcome Measures: Patients will be assessed for their capacity to tolerate IV infusion of MSC without acute clinical or physiological deterioration. Vital signs, pulmonary function tests (FEV1 and FCV) and Borg Dyspnea Index will be evaluated. Chest Radiograph, CBC and serum chemistry will be performed. The overall clinical development strategy of this project is to conduct this Phase I dose escalation study entitled "A pilot Study to Evaluate the Safety and Feasibility of Mesenchymal Stem Cells to Induce Remission in Lung Transplant Patients Experiencing Treatment-Refractory Moderate Lung Rejection". This study will be performed under this current IND application and will be limited to the proposed 9 subjects (3 subjects in each of dose escalating subject cohorts). In this application we are proposing to evaluate safety and feasibility of allogeneic, bone marrow (BM) derived mesenchymal stem cells (MSC) to induce remission of moderate treatment refractory bronchiolitis obliterans (BO/BOS). Lung transplant patients with treatment refractory BO/BOS (grade 3) who do not qualify for a second transplant have near 100% mortality or extreme disability. MSCs are multi-potent cells that have the capacity to induce tissue repair and modulate immune response. They have been used successfully in preclinical and clinical studies to treat … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Mesenchymal Stem Cell Therapy for Lung Rejection – Full …

Cell therapy could slow decline in heart failure patients …

Posted: Published on April 6th, 2016

But that means about 2.5 million Americans live with heart failure that blocks blood vessels and reduces blood supply to the body. A new study provides an early indication that cell therapy using cells from bone marrow could one day help treat heart failure. Researchers gave 60 patients with heart failure an injection of the therapy in the heart and compared their rates of death and heart problems to those of 66 similar patients who received a placebo injection of saltwater in the heart. The researchers found that, during the year following the treatment, the patients who received the cell therapy had a 37% lower rate of death and hospitalization for heart failure-related problems, such as fluid buildup in the body or shortness of breath, compared with the placebo group. In the cell therapy group, 3.4% of the patients died and 51.7% were hospitalized for heart problems, whereas 13.7% of the placebo group died and 82.4% were hospitalized. In the year after the injection, 20.3% of the patients in the cell therapy group experienced an adverse event such as infection or stroke, compared with 41.8% of the placebo group. "It was surprising that the (placebo) patients did significantly worse," Patel … Continue reading →

Posted in Cell Therapy | Comments Off on Cell therapy could slow decline in heart failure patients …

Elsevier Current Opinion – Current Opinion in Biotechnology

Posted: Published on April 6th, 2016

IMPACT FACTOR: 7.117 5-Year Impact Factor: 7.983 Issues per year: 6 issues Editorial Board The Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. In Current Opinion in Biotechnology, we help the reader by providing in a systematic manner: 1. The views of experts on current advances in biotechnology in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications. Division of the subject into sections The subject of biotechnology is divided into themed sections, each of which is reviewed once a year. The amount of space devoted to each section is related to its importance. Analytical biotechnology Plant biotechnology Food biotechnology Energy biotechnology Environmental biotechnology Systems biology Nanobiotechnology Tissue, cell and pathway engineering Chemical biotechnology Pharmaceutical biotechnology Selection of topics to be reviewed Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. … Continue reading →

Posted in Biotechnology | Comments Off on Elsevier Current Opinion – Current Opinion in Biotechnology

DNA Magazine – home

Posted: Published on April 5th, 2016

You do not have JavaScript enabled in your browser so some elements of this website may not appear or work as expected. To learn how to enable javascript, please follow the instructions here. We all know what the eggplant emoji is used for so what happens when you get 4 hot models to do the Eggplant Challenge? Watch the video below to find out! Comments (4) As promised here is part 2 of Three is not a crowd its more FUN! Often we get sent photo shoots for underwear companies, and while we are reluctant to give the free promotion, sometimes we get shoots that are just so damn hot! Comments (4) This is a man of many skills, the self confessed manager, actor, singer, director of musical and opera show, fitness model, VIP coach, Go-go dancer and all round good guy is todays Insta-Stud. Plus he has a smoking hot boyfriend. Comments (2) Spanish model Guillermo Angulo teams up with photographer Alfredo Llorens as we continue to share his vast collection of modelling pics. This series takes Guillermo to a more industrial setting for his latest shoot, and it works a treat! Comments (4) Often we get sent photoshoots … Continue reading →

Posted in DNA | Comments Off on DNA Magazine – home

Bioinformatics – Rochester Institute of Technology

Posted: Published on April 5th, 2016

Bioinformatics is a field that has been developing over the last thirty years. It is a discipline that represents a marriage between biotechnology and computer technologies and has evolved through the convergence of advances in each of these fields. Today bioinformatics is a field that encompasses all aspects of the application of computer technologies to biological data. Computers are used to organize, link, analyze and visualize complex sets of biological data. With the advent of high throughput technologies such as Next Generation Sequencing and proteomics, bioinformatics has become essential to the biological sciences in general. In the past, laboratories were able to manage and analyze their experimental data in spreadsheets. Many research labs now require the expertise of dedicated bioinformatics core centers or their own in-house bioinformaticists. Graduates of our programs have entered such laboratories, both in industry and academia, as bioinformaticists. Some have also gone on to leverage their biotechnology experiences as wet lab experimentalists themselves. The diversity of skills our students cultivate has given them access to a wide range of career choices. If you are interested in becoming a key player in the pivotal role of a bioinformaticist, please read more on our site through the links … Continue reading →

Posted in BioInformatics | Comments Off on Bioinformatics – Rochester Institute of Technology

Stem cells: What they are and what they do – Mayo Clinic

Posted: Published on April 4th, 2016

Stem cells: What they are and what they do Stem cells and derived products offer great promise for new medical treatments. Learn about stem cell types, current and possible uses, ethical issues, and the state of research and practice. By Mayo Clinic Staff You've heard about stem cells in the news, and perhaps you've wondered if they might help you or a loved one with a serious disease. You may wonder what stem cells are, how they're being used to treat disease and injury, and why they're the subject of such vigorous debate. Here are some answers to frequently asked questions about stem cells. Researchers and doctors hope stem cell studies can help to: Generate healthy cells to replace diseased cells (regenerative medicine). Stem cells can be guided into becoming specific cells that can be used to regenerate and repair diseased or damaged tissues in people. People who might benefit from stem cell therapies include those with spinal cord injuries, type 1 diabetes, Parkinson's disease, Alzheimer's disease, heart disease, stroke, burns, cancer and osteoarthritis. Stem cells may have the potential to be grown to become new tissue for use in transplant and regenerative medicine. Researchers continue to advance the knowledge … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Stem cells: What they are and what they do – Mayo Clinic

Mesenchymal Stem Cell: Keystone of the Hematopoietic Stem …

Posted: Published on April 4th, 2016

This site uses cookies to improve performance. If your browser does not accept cookies, you cannot view this site. There are many reasons why a cookie could not be set correctly. Below are the most common reasons: This site uses cookies to improve performance by remembering that you are logged in when you go from page to page. To provide access without cookies would require the site to create a new session for every page you visit, which slows the system down to an unacceptable level. This site stores nothing other than an automatically generated session ID in the cookie; no other information is captured. In general, only the information that you provide, or the choices you make while visiting a web site, can be stored in a cookie. For example, the site cannot determine your email name unless you choose to type it. Allowing a website to create a cookie does not give that or any other site access to the rest of your computer, and only the site that created the cookie can read it. More here: Mesenchymal Stem Cell: Keystone of the Hematopoietic Stem ... … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Mesenchymal Stem Cell: Keystone of the Hematopoietic Stem …

Page 2,028«..1020..2,0272,0282,0292,030..2,0402,050..»